A detailed history of Panagora Asset Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Panagora Asset Management Inc holds 491,854 shares of BMY stock, worth $26.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
491,854
Previous 1,079,067 54.42%
Holding current value
$26.2 Million
Previous $58.5 Million 65.09%
% of portfolio
0.1%
Previous 0.31%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$40.25 - $52.99 $23.6 Million - $31.1 Million
-587,213 Reduced 54.42%
491,854 $20.4 Million
Q1 2024

May 07, 2024

SELL
$47.98 - $54.4 $30.7 Million - $34.8 Million
-639,830 Reduced 37.22%
1,079,067 $58.5 Million
Q4 2023

Feb 08, 2024

SELL
$48.48 - $57.85 $2.72 Million - $3.24 Million
-56,009 Reduced 3.16%
1,718,897 $88.2 Million
Q3 2023

Oct 31, 2023

SELL
$57.89 - $64.73 $1.1 Million - $1.23 Million
-19,061 Reduced 1.06%
1,774,906 $103 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $10.9 Million - $12.1 Million
-171,557 Reduced 8.73%
1,793,967 $115 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $13.4 Million - $15.2 Million
203,611 Added 11.56%
1,965,524 $136 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $1.69 Million - $2 Million
24,632 Added 1.42%
1,761,913 $127 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $62,554 - $37 Million
481,189 Added 38.31%
1,737,281 $124 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $3.4 Million - $3.75 Million
46,861 Added 3.88%
1,256,092 $96.7 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $1.61 Million - $1.93 Million
26,145 Added 2.21%
1,209,231 $88.3 Million
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $8.64 Million - $10.1 Million
-161,177 Reduced 11.99%
1,183,086 $73.8 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $18.4 Million - $21.6 Million
311,191 Added 30.12%
1,344,263 $79.5 Million
Q2 2021

Aug 11, 2021

SELL
$61.91 - $67.42 $14.5 Million - $15.7 Million
-233,472 Reduced 18.43%
1,033,072 $69 Million
Q1 2021

May 12, 2021

BUY
$59.34 - $66.74 $1.36 Million - $1.53 Million
22,933 Added 1.84%
1,266,544 $80 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $2.33 Million - $2.64 Million
-40,409 Reduced 3.15%
1,243,611 $77.1 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $1.42 Million - $1.57 Million
-24,659 Reduced 1.88%
1,284,020 $77.4 Million
Q2 2020

Aug 12, 2020

SELL
$54.82 - $64.09 $5.68 Million - $6.64 Million
-103,679 Reduced 7.34%
1,308,679 $77 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $9.81 Million - $14.3 Million
211,481 Added 17.61%
1,412,358 $78.7 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $11.7 Million - $15.3 Million
238,497 Added 24.78%
1,200,877 $77.1 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $3.23 Million - $3.83 Million
75,504 Added 8.51%
962,380 $48.8 Million
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $11 Million - $12.2 Million
-247,330 Reduced 21.81%
886,876 $40.2 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $86.7 Million - $103 Million
-1,921,480 Reduced 62.88%
1,134,206 $54.1 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $14.6 Million - $18.9 Million
-299,542 Reduced 8.93%
3,055,686 $159 Million
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $126 Million - $142 Million
2,281,987 Added 212.63%
3,355,228 $208 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $15.7 Million - $19.6 Million
311,204 Added 40.84%
1,073,241 $59.4 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $26.5 Million - $30.5 Million
441,754 Added 137.93%
762,037 $48.2 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $3.03 Million - $3.31 Million
-50,580 Reduced 13.64%
320,283 $19.6 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $20.5 Million - $23.6 Million
370,863
370,863 $23.6 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.